These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35262078)

  • 1. Design, Synthesis and Evaluation of Inhibitors of the SARS-CoV2 nsp3 Macrodomain.
    Sherrill LM; Joya EE; Walker A; Roy A; Alhammad YM; Atobatele M; Wazir S; Abbas G; Keane P; Zhuo J; Leung AKL; Johnson DK; Lehtiö L; Fehr AR; Ferraris D
    bioRxiv; 2022 Feb; ():. PubMed ID: 35262078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.
    Sherrill LM; Joya EE; Walker A; Roy A; Alhammad YM; Atobatele M; Wazir S; Abbas G; Keane P; Zhuo J; Leung AKL; Johnson DK; Lehtiö L; Fehr AR; Ferraris D
    Bioorg Med Chem; 2022 Aug; 67():116788. PubMed ID: 35597097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    bioRxiv; 2020 Oct; ():. PubMed ID: 32511412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of a highly conserved isoleucine residue in loop 2 of several β-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication.
    Kerr CM; Pfannenstiel JJ; Alhammad YM; O'Connor JJ; Ghimire R; Shrestha R; Khattabi R; Saenjamsai P; Parthasarathy S; McDonald PR; Gao P; Johnson DK; More S; Roy A; Channappanavar R; Fehr AR
    J Virol; 2024 Nov; 98(11):e0131324. PubMed ID: 39387584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
    Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
    Antiviral Res; 2022 Jul; 203():105344. PubMed ID: 35598780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An MHV macrodomain mutant predicted to lack ADP-ribose binding activity is severely attenuated, indicating multiple roles for the macrodomain in coronavirus replication.
    Voth LS; O'Connor JJ; Kerr CM; Doerger E; Schwarting N; Sperstad P; Johnson DK; Fehr AR
    bioRxiv; 2021 Mar; ():. PubMed ID: 33821264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
    Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
    Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
    Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
    Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
    bioRxiv; 2022 Mar; ():. PubMed ID: 35262075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors.
    O'Connor JJ; Ferraris D; Fehr AR
    Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of a highly conserved isoleucine residue in loop 2 of several
    Kerr CM; Pfannenstiel JJ; Alhammad YM; O'Connor JJ; Ghimire R; Shrestha R; Khattabi R; Saenjamsai P; Parthasarathy S; McDonald PR; Gao P; Johnson DK; More S; Roy A; Channappanavar R; Fehr AR
    bioRxiv; 2024 Jul; ():. PubMed ID: 38260573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.
    Voth LS; O'Connor JJ; Kerr CM; Doerger E; Schwarting N; Sperstad P; Johnson DK; Fehr AR
    J Virol; 2021 Jul; 95(15):e0076621. PubMed ID: 34011547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3.
    Selvaraj C; Dinesh DC; Panwar U; Boura E; Singh SK
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1262-1270. PubMed ID: 33306471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 2-amide-3-methylester thiophenes that target SARS-CoV-2 Mac1 and repress coronavirus replication, validating Mac1 as an anti-viral target.
    Wazir S; Parviainen TAO; Pfannenstiel JJ; Duong MTH; Cluff D; Sowa ST; Galera-Prat A; Ferraris D; Maksimainen MM; Fehr AR; Heiskanen JP; Lehtiö L
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature.
    Correy GJ; Kneller DW; Phillips G; Pant S; Russi S; Cohen AE; Meigs G; Holton JM; Gahbauer S; Thompson MC; Ashworth A; Coates L; Kovalevsky A; Meilleur F; Fraser JS
    Sci Adv; 2022 May; 8(21):eabo5083. PubMed ID: 35622909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain.
    Dasovich M; Zhuo J; Goodman JA; Thomas A; McPherson RL; Jayabalan AK; Busa VF; Cheng SJ; Murphy BA; Redinger KR; Alhammad YMO; Fehr AR; Tsukamoto T; Slusher BS; Bosch J; Wei H; Leung AKL
    ACS Chem Biol; 2022 Jan; 17(1):17-23. PubMed ID: 34904435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and X-ray diffraction at room temperature.
    Correy GJ; Kneller DW; Phillips G; Pant S; Russi S; Cohen AE; Meigs G; Holton JM; Gahbauer S; Thompson MC; Ashworth A; Coates L; Kovalevsky A; Meilleur F; Fraser JS
    bioRxiv; 2022 Feb; ():. PubMed ID: 35169801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response.
    Lee AA; Amick I; Aschenbrenner JC; Barr HM; Benjamin J; Brandis A; Cohen G; Diaz-Tapia R; Duberstein S; Dixon J; Cousins D; Fairhead M; Fearon D; Frick J; Gayvert J; Godoy AS; Griffin EJ; Huber K; Koekemoer L; Lahav N; Marples PG; McGovern BL; Mehlman T; Robinson MC; Singh U; Szommer T; Tomlinson CWE; Vargo T; von Delft F; Wang S; White K; Williams E; Winokan M
    bioRxiv; 2024 Aug; ():. PubMed ID: 39229055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1.
    Rijpkema KJ; Schuller M; van der Veer MS; Rieken S; Chang DLR; Balić P; Todorov A; Minnee H; Wijngaarden S; Matos IA; Hoch NC; Codée JDC; Ahel I; Filippov DV
    Org Lett; 2024 Jul; 26(27):5700-5704. PubMed ID: 38935522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.